-+ 0.00%
-+ 0.00%
-+ 0.00%

CUE BIOPHARMA ANNOUNCES PRECLINICAL SAFETY AND TOLERABILITY DATA FOR CUE-401 FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES

Reuters·02/17/2026 13:00:12

Please log in to view news